Hubbry Logo
Laser medicineLaser medicineMain
Open search
Laser medicine
Community hub
Laser medicine
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Laser medicine
Laser medicine
Laser medicine
View on Wikipedia
from Wikipedia
CW rhodamine dye laser emitting near 590 nm, one typically used in early medical laser systems.
Laser radiation being delivered via a fiber for photodynamic therapy to treat cancer.
A 40-watt CO2 laser with applications in ENT, gynecology, dermatology, oral surgery, and podiatry

Laser medicine is the use of lasers in medical diagnosis, treatments, or therapies, such as laser photodynamic therapy,[1] photorejuvenation, and laser surgery.

The word laser stands for "light amplification by stimulated emission of radiation".[2]

History

[edit]

The laser was invented in 1960 by Theodore Maiman,[3] and its potential uses in medicine were subsequently explored. Lasers benefit from three interesting characteristics: directivity (multiple directional functions), impulse (possibility of operating in very short pulses), and monochromaticity.[4]

Several medical applications were found for this new instrument. In 1961, just one year after the laser's invention, Dr. Charles J. Campbell successfully used a ruby laser to destroy an angiomatous retinal tumor with a single pulse.[5] In 1963, Dr. Leon Goldman used the ruby laser to treat pigmented skin cells and reported on his findings.[6]

The argon-ionized laser (wavelength: 488–514 nm) has since become the preferred laser for the treatment of retinal detachment. The carbon dioxide laser was developed by Kumar Patel and others in the early 1960s and is now a common and versatile tool not only for medicinal purposes but also for welding and drilling, among other uses.[7]

The possibility of using optical fiber (over a short distance in the operating room) since 1970 has opened many laser applications, in particular endocavitary, thanks to the possibility of introducing the fiber into the channel of an endoscope.

During this time, the argon laser began to be used in gastroenterology and pneumology. Dr. Peter Kiefhaber was the first to "successfully perform endoscopic argon laser photocoagulation for gastrointestinal bleeding in humans". Kiefhaber is also considered a pioneer in using the Nd:YAG laser in medicine, also using it to control gastrointestinal bleeding.[8]

In 1976, Dr. Hofstetter employed lasers for the first time in urology. The late 1970s saw the rise of photodynamic therapy, thanks to laser dye. (Dougherty, 1972[9])

Since the early 1980s, applications have particularly developed, and lasers have become indispensable tools in ophthalmology, gastroenterology, and facial and aesthetic surgery.

In 1981, Goldman and Dr. Ellet Drake, along with others, founded the American Society for Laser Medicine and Surgery to mark the specialization of certain branches of medicine thanks to the laser.[10] In the same year, the Francophone Society of Medical Lasers (in French, Société Francophone des Lasers Médicaux) was founded for the same purpose and was first led by Maurice Bruhat.[11]

After the end of the 20th century, a number of centers dedicated to laser medicine opened, first in the OCDE, and then more generally since the beginning of the 21st century.

The Lindbergh Operation was a historic surgical operation between surgeons in New York (United States) and doctors and a patient in Strasbourg (France) in 2001. Among other things, they utilized lasers.

Advantages

[edit]

The laser presents multiple unique advantages that make it very popular among various practitioners.

  • Due to its directional precision, a laser precisely cuts and cauterizes tissues without damaging neighboring cells. It's the safest technique and most precise cutting and cauterizing ever practiced in medicine.
  • Laboratories use lasers extensively, especially for spectroscopy analysis and more generally for the analysis of biochemical samples. It makes it possible to literally "see" and more quickly determine the composition of a cell or sample on a microscopic scale.
  • The electrical intensity of a laser is easily controllable in a safe way for the patient but also variable at will, which gives it a very wide and still partially explored range of uses (in 2021).

Disadvantages

[edit]

The principal disadvantage is not medical but rather economic: its cost. Although its price has dropped significantly in developed countries since its inception, it remains more expensive than most other common technical means due to materials, the technicality of the equipment necessary for the operation of any laser therapy, and the fact that it requires only certain specific training.

For example, in France (as in other countries with a social security system), dental, endodontal or periodontal laser treatment is classified outside the nomenclature and not reimbursed by social security.

Lasers

[edit]

Lasers used in medicine include, in principle, any type of laser, but especially the following:

Applications in medicine

[edit]

Examples of procedures, practices, devices, and specialties where lasers are utilized include the following:

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Laser medicine

View on Grokipedia
from Grokipedia
Laser medicine is a specialized field within medicine that applies laser technology—devices producing coherent, monochromatic, and collimated light through —for diagnostic , therapeutic interventions, and theranostics, enabling precise interactions with biological tissues via photochemical, photothermal, and photomechanical effects. The acronym stands for light amplification by stimulated emission of radiation, a principle first theorized by in 1917 and practically realized in 1960. This technology allows for targeted treatments that minimize damage to surrounding healthy tissue, distinguishing it from traditional surgical methods by offering site-specific, often non-toxic applications in both invasive and non-invasive procedures. The origins of laser medicine trace back to the invention of the first working laser, a , by in 1960, which quickly transitioned from to biomedical applications, including Leon Goldman's 1961 treatment of human skin . The initial clinical use occurred in 1961 for retinal photocoagulation in (initially for conditions like retinal tumors), with treatments for following in the late 1960s, marking the beginning of their integration into medical practice. Key milestones include Leon Goldman's pioneering dermatologic experiments in 1963 on vascular and pigmented lesions, and the 1983 introduction of selective photothermolysis by Anderson and Parrish, which revolutionized precision by confining thermal damage to specific tissue targets based on wavelength absorption by chromophores like or . Over the decades, advancements in laser types—such as CO₂, Nd:YAG, and pulsed-dye lasers—have expanded the field's scope, driven by improvements in , fiber optics, and integration with technologies like MRI-guided systems. Laser medicine spans diverse specialties, with applications tailored to laser wavelengths that interact selectively with tissue components such as , , or pigments. In , common uses include vascular treatment (e.g., port-wine stains with pulsed-dye lasers at 595 nm), and (Nd:YAG or alexandrite lasers), and skin resurfacing for wrinkles or scars (CO₂ or Er:YAG lasers). benefits from lasers in retinal photocoagulation for conditions like and refractive surgeries such as for correction. Surgical applications encompass for fragmenting urinary or biliary stones (:YAG lasers), tumor ablation in via or laser-induced interstitial thermotherapy, and minimally invasive procedures in and , such as atrial fibrillation ablation. utilizes diode and Er:YAG lasers for caries removal and management, while addresses pain, , and across musculoskeletal and neuropathic conditions. The advantages of laser medicine include reduced intraoperative bleeding (up to 54% less in procedures like ), shorter recovery times compared to conventional , and enhanced precision that preserves adjacent structures, thereby lowering complication rates. These benefits stem from the ability to control energy delivery parameters like (ranging from 193 nm UV to 10,600 nm CO₂), pulse duration, and , ensuring , , or as needed. Despite its efficacy, potential risks such as thermal injury, scarring, or pigmentation changes necessitate careful patient selection, protective eyewear, and adherence to safety protocols established by organizations like the FDA since the . Ongoing focuses on , including nanoparticle-enhanced lasers for deeper tissue penetration and theranostic combinations for real-time diagnostics and treatment in cancer management.

History

Early Developments

The foundational concept for laser technology originated from Albert Einstein's theoretical work on of radiation, outlined in his 1917 paper "Zur Quantentheorie der Strahlung," where he described how incoming photons could trigger atoms to emit additional photons in phase, laying the groundwork for coherent light amplification. This principle remained largely theoretical until the mid-20th century, when practical developments began to emerge. The first functional was invented by Theodore H. Maiman in 1960 at Hughes Research Laboratories in , utilizing a synthetic crystal as the gain medium pumped by a flash lamp to produce a coherent beam of red light at 694 nm. Maiman's device, detailed in his seminal publication "Stimulated optical radiation in ," marked the realization of Einstein's and opened possibilities for medical applications, though initial uses were exploratory. The first clinical application of a in occurred in 1961, when ophthalmologist Charles J. Campbell and physicist Charles Koester used a photocoagulator to treat a tumor at Columbia-Presbyterian Medical Center, demonstrating the potential for precise retinal interventions. Subsequent early medical experiments in the 1960s were pioneered in by Leon Goldman, who in 1962–1963 applied ruby lasers to treat and pigment disorders, reporting the selective targeting of dark pigments in for the first time. Goldman's work, including studies on laser effects on structures like nevi and melanomas, demonstrated potential for precise tissue ablation but was limited to rudimentary setups. These initial efforts faced significant challenges, including uncontrolled thermal damage to surrounding tissues due to the lack of precise pulse duration and control in early ruby lasers, often resulting in scarring and non-selective injury. Researchers like Goldman emphasized the need for safety protocols to mitigate risks from unintended energy absorption in biological materials.

Key Milestones and Advancements

The introduction of the argon laser in 1971 marked a pivotal advancement in , enabling precise retinal photocoagulation for conditions like . Developed by researchers such as Christian Zweng, this blue-green wavelength laser (488-514 nm) allowed for targeted coagulation of retinal vessels without the need for invasive procedures, significantly reducing complications compared to earlier xenon arc methods. By 1971, Zweng and colleagues were conducting widespread training courses across the , facilitating rapid clinical adoption and establishing laser therapy as a standard for preserving vision in proliferative . In 1973, the (CO2) laser emerged as a key tool for surgical cutting and vaporization of . Operating at a 10.6 μm with high absorption, the CO2 laser enabled precise incision and in procedures such as tumor resection and dermatological , minimizing blood loss and thermal damage to surrounding tissues. This development represented a significant step, transitioning s from experimental tools to widely used medical devices and spurring innovations in minimally invasive . The 1980s saw the development of lasers, ultraviolet-emitting devices (typically 193 nm argon-fluoride) that revolutionized through photoablation of tissue. These lasers allowed for precise reshaping of the without thermal damage, laying the groundwork for procedures like (PRK). The first human trials for what would become occurred in 1989, performed by Greek ophthalmologist Ioannis Pallikaris, who combined laser ablation with a corneal flap technique, demonstrating improved visual outcomes and faster recovery in early patients. FDA approval for lasers in followed in the 1990s, solidifying their role in correcting , hyperopia, and . Advancements in neodymium-doped aluminum garnet (Nd:YAG) lasers during the expanded their utility in endoscopic procedures and vascular treatments. With a 1064 nm enabling deep tissue penetration, contact and non-contact Nd:YAG systems were refined for gastrointestinal endoscopy, such as visual of the (VLAP) for , introduced in clinical trials around 1993, which offered an alternative to traditional transurethral resection with reduced bleeding. In vascular applications, pulsed Nd:YAG lasers improved the treatment of varicosities and hemangiomas by coagulating blood vessels selectively, with studies in the mid-1990s reporting high success rates in endoscopic coagulation of and other lesions. In the , lasers emerged as a breakthrough for , delivering ultra-short pulses (10^-12 seconds) to shatter ink particles into smaller fragments for easier clearance by the . The first alexandrite laser was introduced in 2013, followed by Nd:YAG variants in 2014, which reduced treatment sessions by up to 50% and minimized side effects like scarring compared to nanosecond Q-switched lasers. Clinical studies demonstrated superior efficacy for multicolored tattoos, with FDA clearances accelerating their adoption in . By 2025, integration of (AI) with systems enhanced precision targeting in procedures like resurfacing and tumor , using algorithms to analyze real-time for optimized delivery and reduced . This AI-laser synergy, as explored in recent dermatological applications, improves outcomes in cosmetic and therapeutic contexts by predicting tissue responses and automating adjustments.

Fundamentals

Principles of Laser-Tissue Interaction

Laser-tissue interactions in primarily occur through three fundamental mechanisms: photothermal, photochemical, and photomechanical effects, each governed by the absorption of energy by specific tissue components. These interactions depend on parameters such as , pulse duration, and , as well as tissue , enabling precise control over therapeutic outcomes. Photothermal effects arise when laser energy is absorbed by tissue chromophores, converting into that can lead to , , or . Key chromophores include , , and , which selectively absorb wavelengths corresponding to their molecular structures; for instance, strongly absorbs mid-infrared , while targets visible wavelengths around 400-600 nm and absorbs broadly in the to visible range. A prominent example is the CO2 at 10,600 nm, which excites vibrational modes in molecules—the primary constituent of soft tissue—resulting in rapid heating to 100°C, tissue , and minimal of about 20 µm due to high absorption. This mechanism is dominant for continuous or long-pulsed , where diffusion determines the extent of thermal damage. Photochemical effects involve non-thermal reactions where absorbed photons trigger chemical changes without significant heating, often requiring specific wavelengths to activate exogenous agents. In (PDT), photosensitizers such as porphyrins accumulate in target tissues and, upon irradiation with (typically 600-800 nm), transition to an excited state, generating like through energy transfer to molecular oxygen. These species induce oxidative damage, leading to and via or , with efficacy depending on the photosensitizer's for production (e.g., 0.43 for m-tetrahydroxyphenylchlorin). This process is fluence-rate dependent and confined to regions of penetration, minimizing collateral effects. Photomechanical effects generate mechanical stress or shockwaves from rapid energy deposition, typically with ultrashort pulses (<1 µs), causing tissue fragmentation without bulk heating. Pulsed lasers induce plasma formation or cavitation bubbles that collapse, producing acoustic waves for applications like lithotripsy, where short pulses create shockwaves to break calculi. These effects are stress-confined when pulse duration is shorter than the optical relaxation time, allowing precise disruption while sparing surrounding structures. The depth of laser penetration into tissue is governed by the Beer-Lambert law, which describes exponential attenuation of light intensity:
I(z)=I0e−μzI(z) = I_0 e^{-\mu z}
where I(z)I(z) is the intensity at depth zz, I0I_0 is the incident intensity, and μ\mu is the effective absorption coefficient influenced by chromophores and scattering. This law highlights how wavelength selection targets specific chromophores, with scattering in tissue often requiring modifications like the differential pathlength factor for accurate dosimetry. A critical factor in photothermal interactions is the thermal relaxation time, defined as the duration for to dissipate from the heated volume, calculated as
τ=d24α\tau = \frac{d^2}{4\alpha}
where dd is the lesion diameter and α\alpha is the thermal diffusivity of the tissue (typically 1.3 × 10-3 cm²/s for water-rich tissues). Pulses shorter than τ\tau (e.g., <1 ms for near-infrared lasers) confine to the absorption site, reducing , whereas longer pulses allow diffusion, increasing the zone of thermal effect. This concept is essential for selective targeting, such as in melanin-rich structures where τ\tau is on the order of microseconds.

Essential Laser Parameters

In laser medicine, the of the emitted is a fundamental that governs selective absorption by specific tissue chromophores, such as , , or , thereby determining the depth of penetration and targeted therapeutic effect. For instance, a of 532 nm is strongly absorbed by , making it suitable for treating superficial vascular lesions by coagulating blood vessels without excessive damage to surrounding tissues. In contrast, longer like 1064 nm exhibit reduced absorption by epidermal , allowing deeper penetration into the , which is particularly advantageous for patients with skin of color to minimize risks of pigmentation changes. This is adjustable in many medical lasers to match the of the target tissue, ensuring precision in applications ranging from to . Power density, also known as and typically measured in watts per square centimeter (W/cm²), dictates the rate of energy delivery to the tissue and plays a critical role in balancing therapeutic outcomes with safety. High power densities, often exceeding several hundred W/cm², enable rapid and of tissue by concentrating energy to cause instantaneous material removal, as seen in procedures requiring precise excision. Conversely, lower power densities promote controlled heating for , where builds gradually to denature proteins and seal vessels without charring or excessive . Optimizing this parameter prevents overheating, which could lead to unintended , and is essential for tailoring treatments to the thermal tolerance of delicate structures like or ocular tissues. Pulse duration represents another key adjustable property, distinguishing continuous wave (CW) operation from pulsed modes ranging from nanoseconds to femtoseconds, and directly influences the spatial confinement of heat within the target volume. Short pulses, such as those in the nanosecond or femtosecond regime, deposit energy faster than the thermal relaxation time of the tissue, minimizing lateral heat diffusion and enabling precise cutting or ablation with negligible thermal spread to adjacent areas. In CW or longer-pulse modes, heat accumulates over time, favoring bulk heating for coagulation or biostimulation rather than sharp dissection. This parameter's selection is guided by the desired laser-tissue interaction, with ultrashort pulses particularly valued for high-resolution procedures where preserving surrounding structures is paramount. Spot size and fluence, the latter defined as energy per unit area in joules per square centimeter (J/cm²), are interconnected parameters crucial for accurate dosimetry and uniform energy distribution across the treatment site. Larger spot sizes reduce divergence and enhance fluence uniformity, allowing deeper penetration for broader areas, while smaller spots concentrate energy for focal treatments. Fluence levels of 5-10 J/cm², for example, are commonly employed in low-fluence protocols for hair removal, achieving selective follicular damage without epidermal injury. These metrics ensure reproducible outcomes by quantifying total energy exposure, preventing under- or over-treatment that could compromise efficacy or induce complications like scarring. Delivery systems facilitate the transmission and shaping of the laser beam from the source to the target, with options including flexible fiber optics for maneuverability in confined spaces, articulated arms for rigid, high-power delivery in surgical settings, and scanners for dynamic beam patterning over irregular surfaces. Fiber optic systems are favored for their portability and minimal beam distortion in endoscopic applications, while articulated arms maintain beam integrity for CO₂ lasers requiring straight-line propagation. Scanners, often integrated with galvanometric mirrors, enable rapid, non-contact scanning to cover larger areas efficiently, as in resurfacing procedures. The choice of delivery system impacts beam quality, alignment precision, and procedural ergonomics, ultimately supporting the safe and effective application of the aforementioned parameters.

Types of Lasers

Gas and Dye Lasers

Gas lasers operate by exciting a of gases within a discharge tube to achieve , where more atoms or molecules are in an than in the , enabling of coherent light. This process typically involves an electrical discharge to energy into the gas medium, producing continuous or pulsed output depending on the design. In medical applications, gas lasers are valued for their ability to deliver specific wavelengths that interact predictably with biological tissues, such as through absorption by or pigments, though they require precise alignment and can demand regular maintenance due to gas replenishment or tube degradation. Excimer lasers, a subtype of gas lasers, utilize short-lived excited dimers (excimers) formed from halides, such as (ArF) or (XeCl), to produce pulsed output through electrical discharge excitation. These lasers emit at fixed wavelengths like 193 nm (ArF) or 308 nm (XeCl), with high enabling precise photochemical without significant . In , the 193 nm is essential for refractive surgeries such as , where it photoablation reshapes corneal tissue for vision correction. The 308 nm variant is used in for targeted phototherapy in conditions like , , and , promoting repigmentation and reducing inflammation in localized areas. The (CO₂) exemplifies a prominent gas in , emitting at a of 10.6 μm in the spectrum, which is strongly absorbed by in tissues, allowing for precise and cutting with minimal lateral . Operating in mode, it achieves high power outputs suitable for ablative procedures on soft tissues, where the localized heating leads to and . in CO₂ occurs between vibrational energy levels of CO₂ molecules in a with and , facilitating efficient energy transfer and stable emission. Argon lasers produce blue-green light at wavelengths of 488 nm and 514 nm, absorbed effectively by and , making them ideal for retinal photocoagulation in to seal leaking vessels or prevent detachment. These ions in an gas discharge tube are excited to achieve , yielding a coherent beam that penetrates ocular media with low . Their versatility in treating vascular retinal conditions stems from the targeted absorption, though careful power control is essential to avoid excessive retinal damage. Helium-neon (HeNe) lasers emit low-power red light at 632.8 nm, commonly used in (LLLT) for , promoting cellular processes like and reducing without thermal effects. In this gas mixture, electrical excitation creates in atoms, resulting in a stable, low-intensity output suitable for non-invasive applications. The shallow penetration of this supports superficial tissue modulation, enhancing proliferation in fibroblasts and epithelial cells. Dye lasers, utilizing organic dye solutions as the gain medium, offer tunable wavelengths across the visible to near-infrared range (approximately 400-800 nm), achieved by selecting different dyes or adjusting cavity optics to exploit broad emission spectra. is established through of dye molecules in a liquid solvent, often by a flashlamp or another laser, leading to rapid relaxation and . In , the pulsed dye laser (PDL) at 585 nm exemplifies selective photothermolysis, targeting oxyhemoglobin in vascular lesions like port-wine stains while sparing surrounding tissue due to pulse durations matching thermal relaxation times. However, these systems require high maintenance, including frequent dye replacement every 3-6 months and solvent filtration to prevent degradation, limiting their practicality compared to solid-state alternatives.

Solid-State and Semiconductor Lasers

Solid-state lasers utilize a solid gain medium, typically a crystal or glass doped with rare-earth ions, to produce coherent light through optical pumping. These lasers employ host matrices such as yttrium aluminum garnet (YAG), which provides mechanical strength and thermal stability due to its robust crystalline structure. The neodymium-doped YAG (Nd:YAG) variant, for instance, operates at a fundamental wavelength of 1064 nm and is widely used in medical settings for its high efficiency and ability to deliver high peak powers. Their solid construction enhances durability, allowing reliable operation in clinical environments with minimal maintenance compared to fluid-based systems. The alexandrite laser, based on chromium-doped chrysoberyl crystals, emits at 755 nm in the near-infrared spectrum and is valued for its high repetition rates and tunable output near this wavelength. is achieved through , enabling effective targeting of and . In , it is commonly used for long-term , particularly in patients with light to tones and dark hair, as well as for treating vascular lesions like spider veins and pigmented lesions through selective photothermolysis. Its superficial penetration suits non-invasive aesthetic procedures with minimal downtime. The Nd:YAG laser, when configured in Q-switched mode, emits short nanosecond pulses suitable for precise tissue fragmentation. It is commonly applied in by targeting pigment particles through photothermal and photomechanical effects, achieving significant clearance with multiple sessions. Additionally, early applications of pulsed Nd:YAG lasers have included for breaking urinary stones via shockwave generation, though modern protocols often favor other wavelengths for routine use. Parameter tuning, such as pulse duration and fluence, optimizes these lasers for specific tissue interactions like or . The , based on chromium-doped aluminum oxide crystals, emits at 694 nm and was among the first solid-state lasers for dermatological treatments. Initially used for pigmented lesions due to strong absorption, it is used in the treatment of pigmented lesions, , and for fair-skinned patients with dark hair, offering long-term reduction through selective photothermolysis. Its red wavelength penetrates superficially, minimizing deeper tissue damage. Erbium-doped YAG (Er:YAG) lasers operate at 2940 nm in the mid-infrared, where water absorption is high, enabling precise ablative resurfacing of with a vaporization depth of about 10-20 μm per pass. This wavelength results in minimal thermal damage to surrounding tissues, promoting faster and reduced scarring in treatments for wrinkles, scars, and actinic damage. The laser's ability to perform multiple passes with integrated cooling further enhances its safety profile for superficial dermatological procedures. Semiconductor lasers, or lasers, differ from traditional solid-state systems by using p-n junction semiconductors as the gain medium, pumped directly by electrical current for compact and efficient operation. Operating in the 800-980 nm near-infrared range, they offer portability and cost-effectiveness, making them ideal for handheld or ambulatory medical devices. In , 980 nm lasers are used for endovenous ablation of , delivering thermal energy to collapse incompetent saphenous veins with high success rates and low recurrence. For , these wavelengths penetrate tissues to stimulate cellular repair and reduce inflammation in conditions like periodontitis, providing adjunctive benefits to conventional treatments without thermal injury.

Advantages and Limitations

Clinical Benefits

Laser medicine offers significant precision in targeting pathological tissues while minimizing damage to surrounding healthy structures, primarily through the principle of selective photothermolysis, which exploits differences in absorption spectra between target chromophores and adjacent tissues. This targeted approach enables minimally invasive treatments, such as the destruction of vascular lesions or pigmented cells, with reduced thermal spread and collateral injury compared to conventional surgical methods. One key advantage is the reduction in intraoperative bleeding and postoperative scarring, achieved via laser-induced through photocoagulation of blood vessels. Studies demonstrate that laser procedures result in significantly lower blood loss than scalpel-based surgeries, leading to clearer operative fields and faster recovery times. Additionally, the controlled tissue vaporization promotes re-epithelialization with minimal fibrotic response, resulting in less prominent scarring and improved cosmetic outcomes over traditional excision techniques. The non-contact nature of laser delivery enhances procedural sterility by avoiding direct instrument-tissue interaction, thereby lowering infection risks, and facilitates access to anatomically challenging sites, such as during endoscopic applications. This attribute is particularly beneficial in confined spaces, where lasers can sterilize the treatment area in real-time through thermal effects. Lasers exhibit versatility across therapeutic modalities, with parameters like , pulse duration, and adjustable to enable for tissue removal, photostimulation for , or for diagnostic guidance. Meta-analyses indicate high for treating various dermatological conditions, underscoring their broad applicability without the need for multiple specialized tools. In the long term, laser medicine proves cost-effective due to shorter hospital stays and fewer required follow-up visits, offsetting initial equipment costs through decreased overall healthcare resource utilization.

Potential Drawbacks and Risks

Laser medicine, while offering precise therapeutic capabilities, carries inherent risks primarily stemming from effects on tissues. Overheating during application can lead to burns, particularly when delivery exceeds the tissue's thermal relaxation time, causing beyond the target area. This thermal injury is exacerbated in procedures using lasers, where prolonged exposure risks deeper tissue . Additionally, postinflammatory or frequently occurs as a complication, with studies on Er:YAG laser resurfacing identifying long pulse durations as a key factor in inducing these pigmentary changes through excessive heat conduction. Patients with darker skin types (Fitzpatrick IV-VI) face heightened susceptibility to these pigmentary alterations due to greater absorption of laser wavelengths, which competes with the intended and amplifies epidermal thermal damage. For instance, in ethnic skin, this absorption increases the risk of postinflammatory following treatments like or resurfacing, necessitating adjusted parameters such as lower fluences to mitigate outcomes. Ocular hazards represent another critical drawback, with stray laser beams posing a significant threat of retinal damage even from indirect exposure during facial or periorbital procedures. Retinal burns can result in permanent vision loss, as evidenced by cases of photothermal from wavelengths like 532 nm or 1064 nm, which penetrate to the and cause photochemical or . Similarly, corneal damage and periocular complications have been reported in dermatologic treatments, underscoring the need for wavelength-specific protective to prevent irreversible harm to both patients and operators. Strict protocols, including protective tailored to the 's emission , are essential to address these risks. The high cost of laser equipment further limits accessibility, posing barriers for adoption in low-resource settings where and add to the financial burden. Emerging low-cost innovations, such as portable lasers, are being explored to improve access in developing regions as of 2024. Efficacy in laser treatments varies considerably due to dependence on operator skill, with and certain pulsed lasers requiring precise control to avoid suboptimal outcomes or complications. In complex cases like scar revision, particularly for hypertrophic or burn-related scars, outcomes can vary due to inconsistencies in fiber placement, energy dosing, and technique. Pulsed applications for burn scars demonstrate but require experienced handling for optimal results. Certain contraindications must be observed to prevent adverse events, including active infections at the treatment site, which can disseminate or worsen under laser-induced thermal stress, making such conditions a general exclusion for ablative procedures. Photosensitive medications, such as tetracyclines or , increase the risk of exaggerated phototoxic reactions, while underlying photosensitivity disorders like further contraindicate therapy due to heightened vulnerability to laser light. Recent sun exposure or tanned skin also elevates complication risks and is typically avoided.

Applications

Dermatological and Aesthetic Uses

Laser medicine has transformed dermatological and aesthetic practices by leveraging selective photothermolysis to target specific chromophores, such as and , while sparing adjacent tissues. This approach enables effective treatment of superficial skin conditions and cosmetic concerns, often with reduced downtime compared to traditional methods. For pigmented lesions like and nevi, the Q-switched Nd:YAG at 1064 nm is a primary tool, delivering short pulses to fragment granules via photomechanical effects. In treatment, low-fluence regimens achieve 50-75% improvement in severity scores after 5-10 sessions, with studies reporting up to 70% patient satisfaction and minimal recurrence when combined with topical agents. For melanocytic nevi, the same yields 70% good-to-excellent clearance after one session and up to 90% after 2-3 sessions, particularly in Asian types, though multiple treatments may be needed for deeper lesions. Vascular malformations, such as infantile hemangiomas, benefit from pulsed dye lasers (PDL) at 595 nm, which selectively coagulate oxyhemoglobin to reduce size and color without significant epidermal damage. Clinical outcomes demonstrate near-complete or complete color clearance in 81% of cases and thickness reduction in 64%, typically after 4-6 sessions spaced 2-8 weeks apart, with low rates of adverse effects like transient (14%). Laser employs (810 nm) and alexandrite (755 nm) lasers to induce follicular heating and thermal damage, leading to long-term reduction. These devices achieve 60-80% count decrease after 3-6 sessions, with sustained results at 6-12 months follow-up, proving safe across types I-V though efficacy varies by color and thickness. Skin resurfacing for wrinkles and scars utilizes fractional CO2 (10,600 nm) and :YAG (2940 nm) lasers, which create microthermal zones to ablate and stimulate dermal remodeling. Aggressive treatments like fractional CO2 yield 26-50% improvement in scar texture and after 2-3 sessions, alongside 50-75% reduction at 3 months, driven by neocollagenesis lasting up to 6 months, but involve longer downtime of 7-14 days and higher risk of side effects such as prolonged redness or pigmentation changes. :YAG offers precise ablation with minimal thermal spread as a gentler alternative, resulting in 3-7 day reepithelialization, quicker recovery, lower risk of side effects, and significant enhancement of rhytides, scars, and photoaged texture, ideal for finer resurfacing. Tattoo removal relies on picosecond lasers (e.g., 755 nm or 1064 nm), which shatter ink particles into fragments small enough for and lymphatic clearance. These lasers provide 75-79% clearance across multicolor tattoos in 1-6.5 treatments, outperforming pulses by reducing sessions needed and minimizing , though complete removal may require 10+ sessions for stubborn pigments.

Ophthalmological and Surgical Uses

Laser medicine plays a pivotal role in , enabling precise interventions for refractive errors, retinal pathologies, and through targeted tissue and photocoagulation without invasive incisions. In , the operating at 193 nm is widely used for procedures such as (PRK) and laser-assisted in situ keratomileusis () to correct by reshaping the . These pulses ablate corneal stroma, flattening the central to improve light focus on the ; each pulse typically removes 0.25–0.6 μm of tissue, allowing for controlled correction with minimal thermal damage. PRK directly ablates the corneal surface after epithelial removal, while involves creating a thin corneal flap to access the stroma, both achieving high predictability in refractive outcomes for moderate . For retinal disorders like proliferative , argon or facilitate panretinal photocoagulation (PRP), a standard treatment that applies hundreds of spots across the peripheral to seal leaky vessels and reduce neovascularization. This destroys ischemic areas, lowering levels and improving oxygenation, thereby decreasing the risk of severe visual loss by over 50% within the first year post-treatment. , emitting at 514 nm, have been the gold standard since the Early Treatment Study, with offering similar efficacy but potentially less discomfort due to their . In glaucoma management, selective laser trabeculoplasty (SLT) employs a 532 nm frequency-doubled Q-switched Nd:YAG to target the , enhancing aqueous humor outflow without significant tissue destruction. The procedure delivers 100 non-overlapping 3 ns pulses of 0.2–1.4 mJ energy over 180° or 360° of the meshwork, selectively heating pigmented cells to promote activity and remodeling, resulting in a 15–25% reduction lasting up to several years. SLT is repeatable and effective across open-angle subtypes, with transient side effects like mild resolving quickly. Beyond , lasers extend to general surgical applications, particularly where precision and are critical in delicate or internal procedures. The CO2 , with its 10.6 μm , excels in cutting for tumor resection and endoscopic surgeries in otolaryngology () and gynecology, vaporizing tissue while simultaneously coagulating vessels up to 0.5 mm in diameter to minimize bleeding. In procedures, such as laryngeal tumor removal, the CO2 enables precise excision under with reduced postoperative compared to traditional scalpels. Gynecological applications include endoscopic of cervical or vulvar lesions, where the laser's non-contact nature preserves surrounding healthy tissue and provides immediate during vaporization. For urinary stone fragmentation, the :YAG laser at 2.1 μm is the preferred tool in , fragmenting calculi through a dominant photothermal mechanism that causes rapid heating and of stone components. Delivered via flexible fibers in ureteroscopy, pulses of 250–350 μs duration and 0.4–1 J energy create starting about 50 μs after initiation, producing calcium-based byproducts and enabling efficient dusting or fragmentation of stones regardless of composition, with minimal retropulsion due to low mechanical stress. This approach has revolutionized endourologic stone management, achieving high success rates for stones up to 2 cm in size.

Oncology and Other Therapeutic Uses

In oncology, lasers play a pivotal role in targeted cancer treatments, particularly through (PDT) and laser interstitial thermal therapy (LITT). PDT utilizes diode lasers emitting at approximately 630-635 nm to activate photosensitizers such as porphyrins, which generate leading to selective destruction of tumor cells while sparing surrounding healthy tissue. This approach is effective for superficial malignancies like skin cancers and early-stage esophageal cancers, where clinical trials have reported complete response rates of up to 82% in T1 squamous cell carcinomas following porphyrin-based PDT. For esophageal applications, PDT with diode lasers has demonstrated prolonged survival in inoperable cases and high efficacy in early lesions, with minimal major complications observed in long-term follow-ups. LITT employs Nd:YAG lasers to deliver for precise of deep-seated tumors, guided by real-time MRI to monitor temperature and tissue response, thereby minimizing damage to adjacent eloquent structures. This minimally invasive technique induces that coagulates tumor tissue, creating zones typically ranging from 3 to 5 cm in diameter depending on laser power (10-15 W) and exposure duration (30-180 seconds). Clinical applications in high-grade gliomas and metastases have shown LITT to be safe and effective for cytoreduction, with low rates of neurological deficits and suitability for patients unsuitable for open . Beyond oncology, low-level laser therapy (LLLT), also known as photobiomodulation, uses helium-neon (HeNe) or diode lasers to promote and reduce in various therapeutic contexts. These lasers stimulate mitochondrial , enhancing ATP production and modulating cellular signaling pathways that decrease pro-inflammatory cytokines. Typical energy densities of 1-5 J/cm² applied in multiple sessions accelerate epithelialization and collagen synthesis in chronic wounds, with studies confirming reduced healing times in diabetic and normal models. For , lasers (typically 800-1064 nm) target musculoskeletal conditions such as and tendinopathies by modulating nerve conduction and reducing nociceptive signaling. This therapy inhibits Aδ- and C-fiber transmission, decreasing perception and , with clinical evidence supporting its use as an adjunct for chronic low-back and , yielding significant reductions in scores after 4-8 weeks of treatment. In , Er:YAG lasers (2940 nm) facilitate cavity preparation and periodontal scaling by ablating hard and soft tissues with minimal thermal damage, owing to their high water absorption coefficient. This wavelength effectively removes carious and while decontaminating root surfaces, reducing bacterial adhesion and spread compared to conventional mechanical methods, as evidenced by inhibition zones in microbial assays and lower generation during procedures. Clinical outcomes include improved periodontal pocket depths and enhanced tissue regeneration without excessive postoperative discomfort.

Safety and Future Directions

Safety Measures and Regulations

Laser safety in medical settings is governed by established standards that classify lasers based on their potential hazards and mandate protective measures. The (ANSI) Z136.1 standard categorizes lasers into classes including Class 1 (safe under reasonably foreseeable conditions), Class 2 (safe due to aversion response), Class 3R (low-power lasers with eye hazards from direct viewing) and Class 3B (higher-power lasers posing eye and skin hazards), and Class 4 (high-power lasers capable of causing severe eye and skin injuries)—to guide safe usage across applications, including medicine. For instance, Class 3B and 4 lasers, common in surgical procedures, require specific protective eyewear with optical density (OD) ratings calculated as OD = log₁₀(incident power or energy / transmitted power or energy), ensuring attenuation to below maximum permissible exposure levels. In the United States, the (FDA) regulates medical lasers through the Center for Devices and Radiological Health (CDRH), which has provided oversight since the Medical Device Amendments of 1976. Manufacturers must obtain 510(k) clearance for these devices, demonstrating substantial equivalence to predicate devices in terms of , biocompatibility, and performance, with submissions including detailed labeling, testing data, and risk analyses. Internationally, standards like IEC 60825-1 provide similar classifications for , while the EU's Medical Device Regulation (MDR) oversees device clearance and post-market surveillance. This process ensures that medical lasers meet standards for electrical , electromagnetic , and biological compatibility before market entry. Operating room protocols emphasize hazard control measures tailored to healthcare environments, as outlined in ANSI Z136.3 for the safe use of lasers in facilities. A key element is defining the Nominal Hazard Zone (NHZ), the spatial region where direct, reflected, or scattered radiation exceeds safe exposure limits, requiring restricted access and like beam enclosures. Facilities must implement interlocks—automatic safety mechanisms that shut down the if protective barriers are breached—and ensure all personnel within the NHZ wear appropriate protective equipment. Additionally, training programs for certified personnel, including Laser Safety Officers (LSOs), cover hazard recognition, standard operating procedures, and emergency responses, with documentation verifying qualifications to comply with regulatory bodies like the (CMS). Patient screening protocols incorporate assessments like the Fitzpatrick skin type classification to mitigate risks such as dyspigmentation during laser treatments, particularly in dermatological applications. This scale, ranging from Type I (very fair skin, always burns) to Type VI (dark skin, never burns), helps clinicians select appropriate laser parameters and predict adverse reactions like post-inflammatory hyperpigmentation in higher types (IV-VI). Such evaluations, combined with discussions on potential complications including eye damage from stray beams, ensure treatments are customized to individual risk profiles. Incident reporting plays a crucial role in enhancing safety, with international bodies like the (WHO) promoting standardized systems to track and learn from adverse events in medical procedures, including those involving lasers. WHO's frameworks encourage global harmonization of reporting to identify patterns in device-related incidents, facilitating updates to guidelines.

Emerging Innovations and Research

Recent advancements in laser medicine are pushing the boundaries of precision and minimally invasive techniques, with ultrafast lasers at the forefront. laser systems, characterized by pulse durations on the order of 10^{-15} seconds, enable highly accurate tissue with minimal due to reduced effects from nonlinear absorption mechanisms. In ophthalmic , these lasers facilitate the creation of corneal flaps for procedures like , offering superior precision and reproducibility compared to mechanical methods, as demonstrated in clinical studies showing standard deviations around 10-15 micrometers in flap thickness for large cohorts. Additionally, lasers combined with nanoparticles have shown promise in nanoparticle-mediated , such as achieving 95% uptake efficiency and 49% mRNA in mouse models, with over 70% cell viability in corneal endothelial cells by confining energy to transient pores without significant heating. Laser-induced plasma techniques are emerging as powerful tools for intraoperative diagnostics, particularly in . Laser-induced breakdown spectroscopy (LIBS) generates plasma through high-energy laser pulses, producing elemental emission spectra that allow real-time analysis of tissue composition for margin detection during tumor resection. Studies from 2015 to 2025 highlight LIBS's ability to differentiate malignant from normal tissues with accuracies up to 99% in and cases when integrated with algorithms like convolutional neural networks, enabling spectroscopic identification of biomarkers such as calcium and iron at tumor boundaries. Similarly, laser-induced plasma spectroscopy (LIPS) has been applied to diagnostics, yielding median scores that distinguish malignant lesions (8.1) from benign ones (1.7) with 81% sensitivity and 72% specificity in preliminary patient trials, supporting its potential for non-invasive, surgical guidance. The integration of lasers with and is revolutionizing targeted therapies, especially for focal treatments. Autonomous robotic systems employing AI-driven beam steering, such as those developed for holmium laser enucleation of the (HoLEP), utilize real-time and mapping to achieve expert-level precision, reducing the procedural and enhancing outcomes in clinical showcases. Clinical trials of AI-augmented focal therapy platforms have reported improvements such as 90% negative margin rates, as seen in software like Unfold AI, which improves patient selection for therapies like high-intensity by minimizing unnecessary tissue . Nanosecond pulsed lasers are gaining traction in antimicrobial photodynamic therapy () to combat antibiotic-resistant . These lasers, with pulse durations around 10^{-9} seconds, activate photosensitizers to generate , effectively targeting biofilms without promoting resistance. A 2024 study on pulsed laser irradiation in PDT demonstrated near-complete eradication, with kill rates approaching 99% against methicillin-resistant Staphylococcus aureus strains , highlighting their efficacy in wound infection models. Portable and wearable diode-based lasers are advancing (LLLT) for at-home management of . These compact devices, often using near-infrared wavelengths around 635-808 nm, deliver non-thermal energy to modulate and analgesia pathways. In 2025, the Erchonia EVRL laser received FDA market clearance as the first LLLT device specifically for , with clinical data showing significant reductions in scores during home-use protocols. Ongoing breakthrough designations underscore their potential, as portable diode systems enable patient-directed sessions that extend clinical benefits beyond hospital settings.

References

  1. https://www.sciencedirect.com/science/article/pii/S1120179719301231
  2. https://medlineplus.gov/ency/article/001913.htm
  3. https://www.nytimes.com/1997/12/07/us/leon-goldman-91-a-research-leader-in-laser-treatment.html
  4. https://www.linkedin.com/pulse/50th-anniversary-first-panretinal-laser-treatment-blindness-gabbay
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC5535675/
  6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220034/
  7. https://www.informationphilosopher.com/solutions/scientists/einstein/1917_Radiation.pdf
  8. https://www.ncbi.nlm.nih.gov/books/NBK232041/
  9. https://pubmed.ncbi.nlm.nih.gov/13948765/
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC4411611/
  11. https://www.lightscalpel.com/blog/laser-history/
  12. https://www.ncbi.nlm.nih.gov/books/NBK555970/
  13. https://crstoday.com/articles/2005-sep/crst0905_16-php
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC3150070/
  15. https://pubmed.ncbi.nlm.nih.gov/3257668/
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC4411606/
  17. http://idnps.com/basics/history-of-aesthetic-laser/6-1-development-of-medical-lasers-in-the-2010s/
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC11909625/
  19. https://pubmed.ncbi.nlm.nih.gov/1589829/
  20. https://www.researchgate.net/publication/253685340_How_tissue_optics_affect_dosimetry_for_photochemical_photothermal_and_photomechanical_mechanisms_of_laser-tissue_interaction
  21. https://www.ncbi.nlm.nih.gov/books/NBK560613/
  22. https://pmc.ncbi.nlm.nih.gov/articles/PMC3999431/
  23. https://pmc.ncbi.nlm.nih.gov/articles/PMC8470722/
  24. https://pubmed.ncbi.nlm.nih.gov/11339391/
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC8553265/
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC4295363/
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC9863268/
  28. https://pmc.ncbi.nlm.nih.gov/articles/PMC10216207/
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC2884838/
  30. https://pmc.ncbi.nlm.nih.gov/articles/PMC5220034/
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC4656495/
  32. https://www.ncbi.nlm.nih.gov/books/NBK557474/
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC12155777/
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC2933784/
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC8348702/
  36. https://pubmed.ncbi.nlm.nih.gov/19916262/
  37. https://www.ncbi.nlm.nih.gov/books/NBK580525/
  38. https://pmc.ncbi.nlm.nih.gov/articles/PMC9541207/
  39. https://www.sciencedirect.com/topics/physics-and-astronomy/carbon-dioxide-laser
  40. https://www.findlight.net/blog/gas-lasers-a-comprehensive-guide/
  41. https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/gas-laser
  42. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290518/
  43. https://pmc.ncbi.nlm.nih.gov/articles/PMC10914410/
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC4398802/
  45. https://www.mdpi.com/2304-6732/12/2/156
  46. https://pmc.ncbi.nlm.nih.gov/articles/PMC2807706/
  47. https://nyaspubs.onlinelibrary.wiley.com/doi/10.1196/annals.1352.040
  48. https://www.sciencedirect.com/science/article/pii/S0022202X15301184
  49. https://www.sciencedirect.com/topics/physics-and-astronomy/dye-laser
  50. https://www.sciencedirect.com/topics/immunology-and-microbiology/pulsed-dye-laser
  51. https://www.sciencedirect.com/science/article/abs/pii/S0190962207002046
  52. https://www.rp-photonics.com/yag_lasers.html
  53. https://www.coherent.com/news/blog/laser-crystals-medical-applications
  54. https://www.hanslaserus.com/knowledge/advantages-disadvantages-and-applications-of-different-types-of-lasers/
  55. https://dermnetnz.org/topics/alexandrite-laser-treatment
  56. https://pubmed.ncbi.nlm.nih.gov/34668826/
  57. https://www.sciencedirect.com/topics/medicine-and-dentistry/laser-lithotripsy
  58. https://www.ncbi.nlm.nih.gov/books/NBK507861/
  59. https://pubmed.ncbi.nlm.nih.gov/10685090/
  60. https://www.ncbi.nlm.nih.gov/books/NBK560931/
  61. https://pmc.ncbi.nlm.nih.gov/articles/PMC8705569/
  62. https://www.coherent.com/resources/white-paper/solutions/medical/COHR_WhitePaper_DiodeLasersForMedicalApplications.pdf
  63. https://pubmed.ncbi.nlm.nih.gov/25786287/
  64. https://europepmc.org/article/med/34425660
  65. https://pmc.ncbi.nlm.nih.gov/articles/PMC5327629/
  66. https://pmc.ncbi.nlm.nih.gov/articles/PMC4745852/
  67. https://pubmed.ncbi.nlm.nih.gov/31050932/
  68. https://pmc.ncbi.nlm.nih.gov/articles/PMC6350396/
  69. https://pmc.ncbi.nlm.nih.gov/articles/PMC9955820/
  70. https://www.spandidos-publications.com/10.3892/etm.2023.11807
  71. https://pubmed.ncbi.nlm.nih.gov/37776370/
  72. https://pubmed.ncbi.nlm.nih.gov/10840426/
  73. https://pubmed.ncbi.nlm.nih.gov/28723036/
  74. https://pubmed.ncbi.nlm.nih.gov/19587691/
  75. https://pubmed.ncbi.nlm.nih.gov/15662626/
  76. https://pubmed.ncbi.nlm.nih.gov/20206094/
  77. https://pmc.ncbi.nlm.nih.gov/articles/PMC5754573/
  78. https://pmc.ncbi.nlm.nih.gov/articles/PMC11431483/
  79. https://pmc.ncbi.nlm.nih.gov/articles/PMC10588089/
  80. https://pubmed.ncbi.nlm.nih.gov/39012840/
  81. https://imlasers.com/articles/surgical-co2-laser-cost/
  82. https://pubmed.ncbi.nlm.nih.gov/9189687/
  83. https://pubmed.ncbi.nlm.nih.gov/20022430/
  84. https://www.ncbi.nlm.nih.gov/books/NBK532248/
  85. https://pmc.ncbi.nlm.nih.gov/articles/PMC10155852/
  86. https://pmc.ncbi.nlm.nih.gov/articles/PMC11626368/
  87. https://pmc.ncbi.nlm.nih.gov/articles/PMC9323185/
  88. https://pmc.ncbi.nlm.nih.gov/articles/PMC3346906/
  89. https://pubmed.ncbi.nlm.nih.gov/19889007/
  90. https://pubmed.ncbi.nlm.nih.gov/31579971/
  91. https://pmc.ncbi.nlm.nih.gov/articles/PMC3580980/
  92. https://my.clevelandclinic.org/health/treatments/11015-laser-skin-resurfacing
  93. https://www.plasticsurgery.org/cosmetic-procedures/laser-skin-resurfacing/recovery
  94. https://pmc.ncbi.nlm.nih.gov/articles/PMC4859414/
  95. https://pmc.ncbi.nlm.nih.gov/articles/PMC7004285/
  96. https://pmc.ncbi.nlm.nih.gov/articles/PMC6823265/
  97. https://pmc.ncbi.nlm.nih.gov/articles/PMC4741175/
  98. https://pubmed.ncbi.nlm.nih.gov/1956663/
  99. https://www.enttoday.org/article/more-than-smoke-and-mirrors-expanding-technology-and-use-of-lasers-in-otolaryngology-head-and-neck-surgery/2/
  100. https://www.sciencedirect.com/topics/nursing-and-health-professions/carbon-dioxide-laser
  101. https://pubmed.ncbi.nlm.nih.gov/10421883/
  102. https://pmc.ncbi.nlm.nih.gov/articles/PMC3799032/
  103. https://pmc.ncbi.nlm.nih.gov/articles/PMC5655312/
  104. https://pmc.ncbi.nlm.nih.gov/articles/PMC10535460/
  105. https://pmc.ncbi.nlm.nih.gov/articles/PMC9713848/
  106. https://pmc.ncbi.nlm.nih.gov/articles/PMC4200616/
  107. https://pmc.ncbi.nlm.nih.gov/articles/PMC6792239/
  108. https://pmc.ncbi.nlm.nih.gov/articles/PMC3914293/
  109. https://pmc.ncbi.nlm.nih.gov/articles/PMC9629480/
  110. https://pmc.ncbi.nlm.nih.gov/articles/PMC7897607/
  111. https://pmc.ncbi.nlm.nih.gov/articles/PMC5523874/
  112. https://pmc.ncbi.nlm.nih.gov/articles/PMC3914322/
  113. https://pmc.ncbi.nlm.nih.gov/articles/PMC8355782/
  114. https://pmc.ncbi.nlm.nih.gov/articles/PMC8946909/
  115. https://pmc.ncbi.nlm.nih.gov/articles/PMC6319951/
  116. https://pmc.ncbi.nlm.nih.gov/articles/PMC7357616/
  117. https://pmc.ncbi.nlm.nih.gov/articles/PMC8666148/
  118. https://pmc.ncbi.nlm.nih.gov/articles/PMC5268770/
  119. https://pmc.ncbi.nlm.nih.gov/articles/PMC8198823/
  120. https://pmc.ncbi.nlm.nih.gov/articles/PMC10750110/
  121. https://www.lia.org/resources/laser-safety-standards/ansi-z1361-safe-use-lasers
  122. https://www.fda.gov/medical-devices/overview-device-regulation/history-medical-device-regulation-oversight-united-states
  123. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-content-and-organization-premarket-notification-medical-laser
  124. https://blog.ansi.org/ansi/ansi-z136-3-2024-safe-use-of-lasers-health-care/
  125. https://www.ncbi.nlm.nih.gov/books/NBK557626/
  126. https://www.who.int/teams/integrated-health-services/patient-safety/research/incident-reporting-and-learning-systems
  127. https://esmed.org/MRA/mra/article/view/4464
  128. https://pubs.acs.org/doi/10.1021/acsanm.5c02133
  129. https://www.mdpi.com/1420-3049/30/21/4176
  130. https://pmc.ncbi.nlm.nih.gov/articles/PMC12385615/
  131. https://www.auanexus.org/innovation-nexus-forum/2025-showcase-presenters
  132. https://bjui-journals.onlinelibrary.wiley.com/doi/full/10.1002/bco2.456
  133. https://pmc.ncbi.nlm.nih.gov/articles/PMC11153266/
  134. https://erchonia-emea.com/lllt/
Add your contribution
Related Hubs
User Avatar
No comments yet.